These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 12445410)

  • 21. [Opiod antagonists and treatment of cholestatic pruritus].
    Sapey T
    Gastroenterol Clin Biol; 1998 Feb; 22(2):255-6. PubMed ID: 9762206
    [No Abstract]   [Full Text] [Related]  

  • 22. Single- and multiple-dose pharmacokinetics of long-acting injectable naltrexone.
    Dunbar JL; Turncliff RZ; Dong Q; Silverman BL; Ehrich EW; Lasseter KC
    Alcohol Clin Exp Res; 2006 Mar; 30(3):480-90. PubMed ID: 16499489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of chronic naltrexone treatment in young autistic children: a double-blind placebo-controlled crossover study.
    Willemsen-Swinkels SH; Buitelaar JK; van Engeland H
    Biol Psychiatry; 1996 Jun; 39(12):1023-31. PubMed ID: 8780837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intranasal abuse potential of an abuse-deterrent oxycodone formulation compared to oxycodone immediate release and placebo in nondependent, recreational opioid users.
    Setnik B; Schoedel K; Bartlett C; Dick C; Hakim N; Geoffroy P
    J Opioid Manag; 2017; 13(6):449-464. PubMed ID: 29308591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gabapentin in patients with the pruritus of cholestasis: a double-blind, randomized, placebo-controlled trial.
    Bergasa NV; McGee M; Ginsburg IH; Engler D
    Hepatology; 2006 Nov; 44(5):1317-23. PubMed ID: 17058231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A clinical trial to determine if corelease of morphine and naltrexone from crushed extended-release capsules induces withdrawal in opioid-dependent patients: a descriptive analysis of six patients.
    Setnik B; Roland CL; Goli V; Sommerville K; Webster L
    J Opioid Manag; 2013; 9(2):139-50. PubMed ID: 23709323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels.
    Younger J; Noor N; McCue R; Mackey S
    Arthritis Rheum; 2013 Feb; 65(2):529-38. PubMed ID: 23359310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A controlled trial of ondansetron in the pruritus of cholestasis.
    O'Donohue JW; Pereira SP; Ashdown AC; Haigh CG; Wilkinson JR; Williams R
    Aliment Pharmacol Ther; 2005 Apr; 21(8):1041-5. PubMed ID: 15813840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adding ultralow-dose naltrexone to oxycodone enhances and prolongs analgesia: a randomized, controlled trial of Oxytrex.
    Chindalore VL; Craven RA; Yu KP; Butera PG; Burns LH; Friedmann N
    J Pain; 2005 Jun; 6(6):392-9. PubMed ID: 15943961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opiate antagonist therapy for the pruritus of cholestasis: the avoidance of opioid withdrawal-like reactions.
    Jones EA; Neuberger J; Bergasa NV
    QJM; 2002 Aug; 95(8):547-52. PubMed ID: 12145394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Injectable extended-release naltrexone (XR-NTX) for opioid dependence: long-term safety and effectiveness.
    Krupitsky E; Nunes EV; Ling W; Gastfriend DR; Memisoglu A; Silverman BL
    Addiction; 2013 Sep; 108(9):1628-37. PubMed ID: 23701526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized trial of long-acting sustained-release naltrexone implant vs oral naltrexone or placebo for preventing relapse to opioid dependence.
    Krupitsky E; Zvartau E; Blokhina E; Verbitskaya E; Wahlgren V; Tsoy-Podosenin M; Bushara N; Burakov A; Masalov D; Romanova T; Tyurina A; Palatkin V; Slavina T; Pecoraro A; Woody GE
    Arch Gen Psychiatry; 2012 Sep; 69(9):973-81. PubMed ID: 22945623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of naltrexone exposure observed in two phase three studies with ALO-02, an extended-release oxycodone surrounding sequestered naltrexone.
    Gimbel JS; Rauck RL; Bass A; Wilson J; Pixton G; Malhotra B; Wilson G; Wolfram G
    J Opioid Manag; 2019; 15(5):417-427. PubMed ID: 31849032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The efficacy and safety of bile Acid binding agents, opioid antagonists, or rifampin in the treatment of cholestasis-associated pruritus.
    Tandon P; Rowe BH; Vandermeer B; Bain VG
    Am J Gastroenterol; 2007 Jul; 102(7):1528-36. PubMed ID: 17403073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of naltrexone in the management of severe generalized pruritus in biliary atresia: report of a case.
    Chang Y; Golkar L
    Pediatr Dermatol; 2008; 25(3):403-4. PubMed ID: 18577062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparative study on the effects of naltrexone and loratadine on uremic pruritus.
    Legroux-Crespel E; Clèdes J; Misery L
    Dermatology; 2004; 208(4):326-30. PubMed ID: 15178915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of low-dose naltrexone in painful diabetic neuropathy: A randomized, double-blind, active-control, crossover clinical trial.
    Srinivasan A; Dutta P; Bansal D; Chakrabarti A; Bhansali AK; Hota D
    J Diabetes; 2021 Oct; 13(10):770-778. PubMed ID: 34014028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse.
    Chick J; Anton R; Checinski K; Croop R; Drummond DC; Farmer R; Labriola D; Marshall J; Moncrieff J; Morgan MY; Peters T; Ritson B
    Alcohol Alcohol; 2000; 35(6):587-93. PubMed ID: 11093966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severe pruritus of cholestasis in disseminated cancer: developing a rational treatment strategy. A case report.
    Zylicz Z; Stork N; Krajnik M
    J Pain Symptom Manage; 2005 Jan; 29(1):100-3. PubMed ID: 15652443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tolerability of naltrexone in treating older, alcohol-dependent patients.
    Oslin D; Liberto JG; O'Brien J; Krois S
    Am J Addict; 1997; 6(3):266-70. PubMed ID: 9256993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.